
P3 Health Partners (PIII) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
373.2M
Operating Income
-38.1M
-10.21%
Net Income
-44.2M
-11.86%
EPS (Diluted)
$-6.28
Balance Sheet Metrics
Total Assets
783.9M
Total Liabilities
662.8M
Shareholders Equity
121.1M
Debt to Equity
5.47
Cash Flow Metrics
Operating Cash Flow
-43.5M
Free Cash Flow
-33.5M
Revenue & Profitability Trend
P3 Health Partners Income Statement From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 1.5B | 1.3B | 1.0B | 491.1M | 145.5M |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 113.9M | 125.6M | 162.4M | 54.9M | 37.2M |
Other Operating Expenses | 1.6B | 1.2B | 1.0B | 464.0M | 147.4M |
Total Operating Expenses | 1.7B | 1.3B | 1.2B | 518.9M | 184.6M |
Operating Income | -312.6M | -167.9M | -246.0M | -28.6M | -39.5M |
Operating Margin % | -20.8% | -13.3% | -23.4% | -5.8% | -27.2% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 22.2M | 16.0M | 11.4M | 2.5M | 2.5M |
Other Non-Operating Income | 28.8M | 184.0K | -1.3B | -290.7K | 98.0K |
Pre-tax Income | -306.0M | -183.7M | -1.6B | -31.4M | -42.0M |
Income Tax | 4.4M | 2.7M | 1.9M | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -310.4M | -186.4M | -1.6B | -31.4M | -42.0M |
Net Margin % | -20.7% | -14.7% | -148.8% | -6.4% | -28.8% |
Key Metrics | |||||
EBITDA | -225.1M | -81.5M | -155.9M | -28.1M | -39.0M |
EPS (Basic) | $-47.00 | $-0.61 | $-6.50 | $-0.46 | $-0.62 |
EPS (Diluted) | $-54.00 | $-0.63 | $-6.50 | $-0.46 | $-0.62 |
Basic Shares Outstanding | 2903500 | 94889000 | 41600000 | 68159532 | 68159532 |
Diluted Shares Outstanding | 2903500 | 94889000 | 41600000 | 68159532 | 68159532 |
Income Statement Trend
P3 Health Partners Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 38.8M | 36.3M | 17.5M | 140.5M | 36.3M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 121.3M | 118.5M | 72.1M | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | 14.4M | 3.6M | 2.6M | 7.0M | - |
Total Current Assets | 184.1M | 166.0M | 100.7M | 199.9M | 90.9M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.1M | 1.1M | 1.1M | 451.0K | 5.2M |
Goodwill | 574.4M | 666.7M | 751.0M | 3.5B | 1.7M |
Intangible Assets | 574.4M | 666.7M | 751.0M | 835.8M | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 19.2M | 19.5M | 16.0M | 10.6M | - |
Total Non-Current Assets | 599.3M | 695.0M | 775.9M | 2.2B | 15.6M |
Total Assets | 783.4M | 861.0M | 876.6M | 2.4B | 106.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 64.0M | 43.7M | 25.2M | 5.5M | 11.8M |
Short-term Debt | 65.0M | - | - | 3.6M | 90.0K |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 353.0K | - | - | - | - |
Total Current Liabilities | 496.4M | 299.4M | 241.7M | 198.8M | 90.6M |
Non-Current Liabilities | |||||
Long-term Debt | 101.2M | 121.9M | 105.9M | 86.3M | 49.0M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 26.0M | 4.9M | 4.8M | 3.5M | - |
Total Non-Current Liabilities | 137.5M | 127.9M | 112.2M | 101.2M | 55.3M |
Total Liabilities | 633.9M | 427.3M | 353.9M | 299.9M | 146.0M |
Equity | |||||
Common Stock | 36.0K | 32.0K | 24.0K | 24.0K | 90.7M |
Retained Earnings | -503.2M | -367.3M | -309.5M | -39.4M | -130.5M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 149.5M | 433.7M | 522.7M | 2.1B | -39.5M |
Key Metrics | |||||
Total Debt | 166.2M | 121.9M | 105.9M | 89.9M | 49.1M |
Working Capital | -312.3M | -133.4M | -141.0M | 1.1M | 264.5K |
Balance Sheet Composition
P3 Health Partners Cash Flow Statement From 2019 to 2024
Metric | 2024 | 2023 | 2022 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -310.4M | -186.4M | -1.6B | -31.4M | -42.0M |
Depreciation & Amortization | 86.1M | 86.7M | 87.3M | 795.2K | 399.2K |
Stock-Based Compensation | 5.8M | 6.0M | 19.4M | 447.5K | 474.0K |
Working Capital Changes | -6.0M | -26.5M | -17.0M | -23.4M | -8.5M |
Operating Cash Flow | -230.4M | -119.7M | -1.5B | -54.1M | -51.3M |
Investing Activities | |||||
Capital Expenditures | 0 | -1.8M | -2.2M | -2.9M | -1.5M |
Acquisitions | - | 0 | -5.5M | -130.0K | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 14.5M | -1.8M | -7.7M | -3.2M | -3.9M |
Financing Activities | |||||
Share Repurchases | - | - | - | -180.0K | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 88.1M | 14.1M | 15.0M | 36.4M | 16.2M |
Debt Repayment | -31.0M | 0 | -3.6M | -1.5M | -14.6M |
Financing Cash Flow | 27.3M | 100.3M | 7.8M | 34.8M | 63.6M |
Free Cash Flow | -110.1M | -77.9M | -128.3M | -27.5M | -29.7M |
Net Change in Cash | -188.6M | -21.2M | -1.5B | -22.5M | 8.5M |
Cash Flow Trend
P3 Health Partners Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-0.15
Forward P/E
-34.14
Price to Book
0.53
Price to Sales
1.00
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-9.99%
Operating Margin
-9.59%
Return on Equity
-141.55%
Return on Assets
-24.31%
Financial Health
Current Ratio
0.31
Debt to Equity
221.06
Beta
0.80
Per Share Data
EPS (TTM)
$-51.33
Book Value per Share
$13.60
Revenue per Share
$448.83
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
piii | 1.5B | -0.15 | 0.53 | -141.55% | -9.99% | 221.06 |
HCA Healthcare | 94.2B | 16.91 | -76.81 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.18 | 4.20 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 1.9B | 13.80 | 0.62 | 4.83% | 4.31% | 74.74 |
Select Medical | 1.8B | 23.21 | 1.07 | 7.72% | 3.33% | 136.22 |
Pacs | 1.8B | 19.41 | 3.15 | 110.96% | 2.59% | 469.36 |
Financial data is updated regularly. All figures are in the company's reporting currency.